INSERTIONSVORRICHTUNG FÜR EIN INFUSIONSSET

European patent · EP2979713 · In force

Register entry

Publication number
EP2979713
Application number
EP15175975
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 9, 2015
Published
Feb 3, 2016
Granted
Oct 9, 2019
Protection ends at the latest
Jul 8, 2035
Next annual fee due
Jul 31, 2027
IPC classes
A61M 5/158 (2006.01)
Priority
CH 11572014 29.07.2014
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Feb 25, 2026

    Transferred

    Owner
    Ypsomed AG, Brunnmattstrasse 6, 3401 Burgdorf → mylife Diabetes Care AG, Lyssachstrasse 40, 3400 Burgdorf
    Representative
    IP Abteilung -mylife Diabetes Care AG, Lyssachstrasse 40, 3400 Burgdorf

    Published in Swissreg on 25.02.2026

  3. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  4. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  5. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  6. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  7. Oct 27, 2020

    Transferred

    Owner
    TecPharma Licensing AG, Brunnmattstrasse 6, 3401 Burgdorf → Ypsomed AG, Brunnmattstrasse 6, 3401 Burgdorf

    Published in Swissreg on 27.10.2020

  8. Oct 9, 2019

    Granted

    Published in Swissreg on 09.10.2019

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.